Hint mode is switched on Switch off
For swift navigation between sections

SomaLogic

PDF download

Choose all Reset all
Download Cancel
Organization name
SomaLogic Inc (formerly CM Life Sciences II Inc)
Country name
USA
Country of registration
USA
Industry
Professional Services
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

SomaLogic Inc (formerly CM Life Sciences II Inc) operates as a protein biomarker discovery and clinical diagnostics company. The Company offers equipment to detect cancer development, onset of metabolic diseases, state of nutrition, and future risk of stroke and heart attack. SomaLogic serves the healthcare industry in the United States.

Awards

News

04/01/2024 SomaLogic: Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
02/01/2024 SomaLogic: Regulation Fd Disclosure, Financial Statements And Exhibits
29/12/2023 Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote "FOR" Proposed Merger with Standard BioTools
29/12/2023 SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders
29/12/2023 SomaLogic: Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001837412
  • EIN
    85-4298912
Registration is required to get access.